ISO 15189:2022 - Medical Laboratory Internal Auditor Free Practice Test — 30 Questions

Question 1

During an internal audit of a clinical chemistry laboratory, an auditor identifies a recurring issue with a specific immunoassay test showing an increasing trend of out-of-specification results over the past quarter. The laboratory management has documented a corrective action plan, which includes recalibration of the instrument and retraining of the analyst. As an internal auditor, what is the most critical step to verify the effectiveness of this corrective action?

Accepted Answer

Reviewing the documented recalibration logs and retraining records to confirm completion of the planned activities.

Question 2

An internal auditor is reviewing the laboratory\'s process for handling results that fall outside established analytical performance specifications. The laboratory has identified several instances where critical patient results were initially reported but later found to be erroneous due to instrument drift. The auditor needs to assess the effectiveness of the laboratory\'s system for managing these non-conforming examinations. Which of the following audit objectives would most comprehensively evaluate the laboratory\'s adherence to ISO 15189:2022 requirements for such situations?

Accepted Answer

Verify that documented procedures for identifying, evaluating, segregating, and disposing of non-conforming examinations are in place and consistently applied, with evidence of review and corrective actions taken to prevent recurrence.

Question 3

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor observes that while the laboratory has a documented procedure for handling non-conforming results, the records indicate a significant delay in the review and disposition of several critical patient samples that were initially flagged for analytical issues. The laboratory director states that the team is overwhelmed with routine workload. Which of the following best describes the auditor\'s primary finding regarding the laboratory\'s adherence to the standard\'s requirements for managing non-conforming outputs?

Accepted Answer

The laboratory's process for managing non-conforming outputs is not being consistently implemented and documented as required by the standard, leading to potential risks to patient care and data integrity.

Question 4

During an internal audit of a clinical laboratory, an auditor is reviewing the process for introducing a new immunoassay for a critical analyte. The laboratory has completed the analytical validation and verification studies, demonstrating acceptable performance characteristics. What is the primary focus for the auditor to ensure compliance with ISO 15189:2022 regarding this new method\'s implementation?

Accepted Answer

Verification that a documented risk assessment and mitigation plan for the method's introduction, including potential impacts on workflow and patient care, was conducted and approved prior to routine use.

Question 5

During an internal audit of a medical laboratory, a nonconformity was identified regarding the inconsistent calibration of a critical diagnostic analyzer, leading to potential variability in patient test results. The laboratory management provided documentation indicating that the instrument was recalibrated by a qualified technician and the associated logbook was updated. As an internal auditor, what is the most crucial step to verify the effectiveness of the corrective action taken?

Accepted Answer

Reviewing evidence that demonstrates the recalibration has resolved the inconsistency and prevented recurrence of the issue.

Question 6

During an internal audit of the hematology department, an auditor discovers that a critical reagent for a commonly ordered coagulation test has been in use for the past three weeks without undergoing the full validation process required by the laboratory\'s standard operating procedures and the laboratory\'s quality manual, which aligns with ISO 15189:2022 requirements. This reagent is essential for providing timely patient results for anticoagulant therapy monitoring. What is the most appropriate immediate action for the internal auditor to take upon discovering this significant procedural deviation?

Accepted Answer

Immediately report the finding to the laboratory director and the quality manager, highlighting the potential impact on patient results and the deviation from validated procedures.

Question 7

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor observes that the established quality objective for the turnaround time of STAT coagulation tests has been consistently missed by an average of 15% over the past quarter. Furthermore, the auditor finds no documented evidence of a root cause analysis or any initiated corrective action process by the laboratory\'s quality management team to address this persistent shortfall, despite the laboratory\'s own documented procedure for managing nonconformities. What is the most appropriate immediate action for the internal auditor to take regarding this observation?

Accepted Answer

Formally document the unmet quality objective as a nonconformity in the audit report, requiring the laboratory to initiate a corrective action process.

Question 8

A medical laboratory performing complex molecular diagnostic tests discovers a batch of reagents that exhibits an unexpected drift in performance, leading to a statistically significant deviation in control material results. The laboratory director is reviewing the internal audit findings related to this incident. Which individual or role within the laboratory is ultimately responsible for authorizing the disposition of patient samples tested using the affected reagent batch, considering the potential impact on patient care and regulatory compliance?

Accepted Answer

The laboratory director or a designated senior medical scientist with appropriate authority and expertise.

Question 9

During an internal audit of a clinical chemistry laboratory, an auditor discovers that a critical spectrophotometer, essential for multiple quantitative assays, has not been recalibrated according to the documented, validated schedule for the past three months. This deviation was not identified by the laboratory\'s internal quality control procedures or by staff. What is the most significant implication of this finding for the laboratory\'s quality management system as assessed by the internal auditor?

Accepted Answer

The laboratory's system for monitoring and verifying the performance of critical analytical equipment is demonstrably ineffective, potentially compromising the accuracy and reliability of patient test results.

Question 10

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor observes that a specific reagent\'s expiry date was not clearly marked on its secondary container, although the primary container was correctly labeled and the reagent was still within its valid shelf life. This observation is classified as a minor nonconformity. What is the most appropriate immediate action for the auditor to recommend to the laboratory management regarding this finding?

Accepted Answer

Document the nonconformity, initiate a root cause analysis to understand why the secondary container was not properly labeled, and recommend corrective actions to prevent recurrence.

Question 11

During an internal audit of a clinical pathology laboratory\'s quality management system, an auditor observes that the laboratory\'s documented procedure for managing updates to its Laboratory Information System (LIS) lacks specific requirements for independent validation of the updated software before its full implementation. The auditor also notes that there is no clear record of validation activities for the most recent LIS update, which was applied three months prior. Considering the potential impact on data integrity and patient safety, what is the most appropriate course of action for the internal auditor to take according to the principles of ISO 15189:2022?

Accepted Answer

Document the absence of a validated procedure for LIS software updates as a nonconformity and recommend the development and implementation of a robust validation process.

Question 12

During an internal audit of a clinical chemistry laboratory, an auditor observes that a specific lot of a critical diagnostic reagent, which has not undergone the laboratory\'s full validation process, has been consistently used for patient testing for the past three months. This practice deviates from the laboratory\'s documented standard operating procedure for reagent introduction and the general requirements for analytical quality outlined in ISO 15189:2022. What is the most appropriate immediate action for the internal auditor to take in accordance with their role and the standard?

Accepted Answer

Document the observation as a nonconformity, referencing the relevant clauses of ISO 15189:2022 and the laboratory's own procedures, and report it to the laboratory director for management review and initiation of corrective action.

Question 13

An internal auditor is reviewing the quality management system of a busy clinical pathology laboratory. During the audit, it is discovered that a critical patient result for a coagulation assay was reported to the attending physician before the instrument used for the test had completed its full diagnostic self-check cycle, which had been interrupted by a transient power fluctuation. The laboratory\'s standard operating procedure (SOP) for instrument downtime and recovery requires a full diagnostic cycle and manual verification of critical results following any power interruption. The initial investigation by the laboratory manager indicates that the result was later found to be within the expected physiological range, but the documentation regarding the interruption, the decision to release the result, and the subsequent verification steps is incomplete and lacks a formal review. Which of the following represents the most accurate and relevant finding for the internal auditor to record concerning this incident?

Accepted Answer

The laboratory failed to implement its documented procedures for managing nonconforming work, specifically regarding the identification, evaluation, and disposition of the unverified critical result, and lacked evidence of appropriate corrective actions.

Question 14

During an internal audit of a medical laboratory, it was discovered that a batch of critical patient results for a specific biochemical marker was flagged as potentially compromised due to a documented reagent stability issue. The laboratory immediately ceased the release of all pending results associated with that reagent lot and initiated an investigation into the reagent\'s performance and the extent of the impact on previously reported results. Which of the following actions, if documented and consistently applied by the laboratory, would best demonstrate compliance with the principles of managing non-conforming examinations under ISO 15189:2022?

Accepted Answer

Thoroughly investigating the root cause of the reagent stability issue, implementing corrective actions to prevent recurrence, and verifying the effectiveness of these actions, while also ensuring appropriate communication and re-testing where necessary for affected patient results.

Question 15

An internal auditor, during a routine audit of the hematology department, discovers a batch of 50 patient samples that were processed using a reagent lot that had expired the previous day. The laboratory\'s standard operating procedure for reagent management is clear about discarding expired reagents. This batch of samples has not yet been resulted or released to clinicians. The laboratory personnel responsible for reagent stock have not yet identified or reported this issue. What is the most appropriate immediate action for the internal auditor to take in accordance with ISO 15189:2022 requirements for managing nonconforming work?

Accepted Answer

Immediately report the finding to the laboratory director or designated management representative for assessment and action.

Question 16

During an internal audit of a clinical chemistry laboratory, an auditor observes that a critical reagent used for a high-volume diagnostic test has not been recertified within the timeframe specified in the laboratory\'s own Standard Operating Procedure (SOP) for reagent management. The SOP clearly states a recertification interval of 6 months, and the current reagent lot was last recertified 7 months ago. The laboratory personnel involved state that they have been busy with increased sample volumes and that this oversight was unintentional. Which of the following actions by the internal auditor best reflects the requirements for documenting findings according to ISO 15189:2022 and the principles of effective auditing?

Accepted Answer

Document the observation as a nonconformity, detailing the specific SOP clause not met and the evidence of the expired recertification date, and report it for corrective action.

Question 17

During an internal audit of a clinical chemistry laboratory, an auditor revisits a previously identified nonconformity concerning the inconsistent calibration of a vital spectrophotometer, which impacts several quantitative assays. Upon re-examination, it is evident that the corrective actions implemented by the laboratory management have not resolved the issue, as the instrument\'s calibration records still exhibit deviations beyond acceptable limits, potentially compromising the accuracy of patient results. What is the most appropriate course of action for the internal auditor in this scenario, according to the principles of ISO 15189:2022?

Accepted Answer

Document the recurrence of the calibration issue as a new nonconformity, requiring a re-evaluation of the original corrective action plan and the implementation of more effective measures.

Question 18

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor discovers a batch of patient samples that were processed using an instrument that had recently experienced a minor calibration drift, potentially affecting the accuracy of several test results. The laboratory has a quality management system in place. What is the most critical aspect for the internal auditor to verify regarding the handling of these potentially compromised examinations to ensure compliance with the standard?

Accepted Answer

The existence and effective implementation of a documented procedure for identifying, evaluating, controlling, and reporting non-conforming examinations, including communication of findings.

Question 19

During an internal audit of a clinical chemistry laboratory, an auditor reviews a sample of patient records from the past quarter. It is discovered that for 15% of the reviewed samples, the associated raw data logs and calibration records for the specific analytical runs are either incomplete or entirely absent. This deficiency spans across multiple analytical platforms and affects a significant number of patient results, hindering complete traceability. Considering the requirements of ISO 15189:2022 regarding record management and the auditor\'s role in assessing conformity, what is the most appropriate classification and immediate action for this finding?

Accepted Answer

Classify as a major nonconformity and report the systemic failure in record management to laboratory management for immediate corrective action.

Question 20

During an internal audit of the pre-examination phase at a medical laboratory, an auditor discovers that the laboratory has implemented a new automated sample tracking system to mitigate the risk of sample misidentification, a risk previously identified in their risk management plan. What is the primary focus of the auditor\'s evaluation regarding this implemented control?

Accepted Answer

Verification of the system's documented implementation and evidence of its effectiveness in reducing the identified risk of sample misidentification.

Question 21

During an internal audit of the hematology department at a clinical laboratory accredited to ISO 15189:2022, an auditor discovers that a primary analyzer for complete blood counts has not been subjected to its scheduled preventative maintenance and calibration checks for the past three months, despite the laboratory\'s documented procedure requiring these activities quarterly. The laboratory\'s quality manager states that the maintenance logs are incomplete and that the instrument\'s performance has not been formally verified against traceable standards during this period. What is the internal auditor\'s most immediate and appropriate course of action according to the principles of ISO 15189:2022 for internal audits?

Accepted Answer

Document the uncalibrated and unmaintained equipment as a nonconformity and report it to laboratory management for immediate corrective action.

Question 22

During an internal audit of a clinical pathology laboratory, an auditor observes a recurring pattern where critical results, flagged for recheck due to initial discrepancies, are being released for patient reporting without explicit documented authorization from a designated supervisor or quality manager. The laboratory\'s standard operating procedure for critical result management mandates such authorization for any deviation from routine reporting. What is the most appropriate course of action for the internal auditor to recommend to address this systemic issue, ensuring compliance with ISO 15189:2022 requirements?

Accepted Answer

Recommend a thorough review and reinforcement of the laboratory's documented procedures for managing nonconforming work, focusing on the authorization and documentation requirements for the release of critical results that have undergone retesting due to initial discrepancies.

Question 23

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor discovers that a critical patient result for a coagulation test was initially reported prematurely due to an unexpected instrument calibration failure that was later resolved. The laboratory\'s documented procedure for managing nonconforming work requires immediate notification to the requesting physician and the patient\'s record to be flagged. However, in this instance, the laboratory staff only corrected the instrument and re-ran the sample, with no record of physician notification or internal documentation of the event as a nonconformity. What is the primary finding the internal auditor should focus on in their report regarding this situation?

Accepted Answer

Failure to adhere to the laboratory's documented procedure for managing nonconforming work, specifically concerning the communication of critical results and the internal recording of the event.

Question 24

Consider a scenario at a clinical pathology laboratory where an internal audit reveals that a critical diagnostic assay\'s incubation step was consistently performed with a temperature deviation of $ \pm 1.5^\circ C $ outside the validated range for a period of two weeks due to a faulty incubator thermostat. This deviation occurred during the processing of approximately 150 patient samples. What is the most appropriate course of action for the laboratory director, acting as the quality manager, to ensure compliance with ISO 15189:2022 and maintain patient safety?

Accepted Answer

Immediately review all 150 patient samples processed during the deviation period, re-test those where the impact assessment indicates a potential for significant error, and communicate any necessary corrections to the requesting clinicians, ensuring thorough documentation of all actions.

Question 25

During an internal audit of a clinical chemistry laboratory, an auditor observes that a specific reagent used for a critical diagnostic test was prepared using a slightly modified dilution factor compared to the manufacturer\'s instructions and the laboratory\'s own standard operating procedure (SOP). The SOP explicitly states adherence to the manufacturer\'s guidelines unless a validated alternative method is approved. The auditor notes this discrepancy during the process verification phase. What is the most appropriate immediate action for the internal auditor to take regarding this observation?

Accepted Answer

Assess the potential impact of the modified dilution factor on the accuracy and reliability of patient test results and patient safety.

Question 26

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor observes that a specific validated immunoassay method for a critical analyte is being performed with reagent lot numbers that have not been explicitly approved and documented by the laboratory director, despite the laboratory\'s own Standard Operating Procedure (SOP) requiring such approval for all reagents used in patient testing. This deviation from the SOP is noted across several testing days and by different technologists. What is the internal auditor\'s most immediate and critical responsibility upon identifying this specific instance of noncompliance?

Accepted Answer

Document the observed deviation from the SOP, detailing the specific reagent lot numbers, the affected tests, and the personnel involved, as a nonconformity.

Question 27

During an internal audit of a medical laboratory accredited to ISO 15189:2022, an auditor observes that a critical quality control parameter for a specific immunoassay was not met during the previous shift. The laboratory\'s documented procedure for handling such events requires immediate investigation, re-testing of affected patient samples, and notification of the clinical pathologist. However, the auditor finds no record of any investigation or notification having taken place for this specific instance. What is the auditor\'s most appropriate immediate action according to the principles of internal auditing and ISO 15189:2022?

Accepted Answer

Formally document the observed deviation as a nonconformity in the audit report, detailing the specific quality control failure and the lack of adherence to the laboratory's procedure.

Question 28

During an internal audit of a medical laboratory\'s quality management system, an auditor reviews a nonconformity report concerning a consistent trend of slightly elevated results for a specific immunoassay. The laboratory documented a corrective action: retraining of the analyst performing the assay. The auditor\'s follow-up verification should primarily focus on which of the following to confirm the effectiveness of this corrective action?

Accepted Answer

Reviewing subsequent quality control data and proficiency testing results for that specific immunoassay to ascertain if the elevated results have ceased and performance has returned to acceptable limits.

Question 29

During an internal audit of a clinical pathology laboratory accredited to ISO 15189:2022, an auditor observes that when a critical diagnostic test fails to meet its established quality control specifications, the laboratory personnel do not consistently follow a defined process for its segregation, evaluation, and subsequent disposition. Instead, decisions regarding whether to report the results or re-run the test are made on an ad-hoc basis by individual technologists. What is the most appropriate recommendation for the internal auditor to make to address this systemic issue?

Accepted Answer

Recommend the immediate establishment and implementation of a documented procedure for the identification, evaluation, segregation, and disposition of non-conforming examinations, ensuring that authorized personnel make decisions regarding their use and that corrective actions are documented.

Question 30

An internal audit of a clinical pathology laboratory reveals that a critical patient result for a coagulation test was initially reported with an erroneous value due to a calibration drift in the analytical instrument. The laboratory\'s quality manager has since corrected the result and reissued the report to the clinician. As an internal auditor tasked with assessing compliance with ISO 15189:2022, which of the following actions would most effectively verify the laboratory\'s adherence to the requirements for managing nonconforming outputs?

Accepted Answer

Review the laboratory's documented procedure for managing nonconforming results and examine records of the identified calibration drift, the investigation into its cause, the corrective actions implemented, and evidence of any necessary patient notification and re-verification of the corrected result.

ISO 15189:2022 - Medical Laboratory Internal Auditor Free Practice Test — 30 Questions

A lot more is already mapped out

About the ISO 15189:2022 - Medical Laboratory Internal Auditor Certification